Sabby Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-881,585
| Closed | -$512K | – | 250 |
|
2016
Q2 | $512K | Sell |
881,585
-2,435,934
| -73% | -$1.41M | 0.03% | 111 |
|
2016
Q1 | $4.84M | Buy |
3,317,519
+2,399,577
| +261% | +$3.5M | 0.24% | 12 |
|
2015
Q4 | $2.94M | Buy |
917,942
+345,424
| +60% | +$1.11M | 0.16% | 24 |
|
2015
Q3 | $3.58M | Buy |
572,518
+244,118
| +74% | +$1.53M | 0.15% | 38 |
|
2015
Q2 | $3.26M | Buy |
+328,400
| New | +$3.26M | 0.12% | 35 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 222 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 196 |
|
2014
Q3 | – | Hold |
0
| – | – | – | 198 |
|
2014
Q2 | – | Hold |
0
| – | – | – | 179 |
|
2014
Q1 | – | Hold |
0
| – | – | – | 177 |
|
2013
Q4 | – | Sell |
-978,359
| Closed | -$3.28M | – | 162 |
|
2013
Q3 | $3.28M | Buy |
978,359
+107,816
| +12% | +$361K | 0.21% | 12 |
|
2013
Q2 | $2.91M | Buy |
+870,543
| New | +$2.91M | 0.19% | 15 |
|